BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2382263)

  • 1. Biochemical characterization of the membrane-associated phosphorylating proteins involved in the anti-proliferative effect of human recombinant interferon-alpha 2a (rIFN-alpha 2a) in Daudi cells.
    Yokoyama M; Koike K; Kanno S; Ohtsuki K
    Tohoku J Exp Med; 1990 Apr; 160(4):343-59. PubMed ID: 2382263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth inhibition of melanoma cells by interferons in vitro. Similar antiproliferative effects of 100-1000 times lower concentrations of nIFN-beta in comparison with rIFN-alpha-2a].
    Zouboulis C; Garbe C; Orfanos CE
    Hautarzt; 1989 Feb; 40(2):65-9. PubMed ID: 2714987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of indomethacin, aspirin, and acetaminophen on in vitro antiviral and antiproliferative activities of recombinant human interferon-alpha 2a.
    Takaoki M; Yamashita Y; Koike K; Matsuda S
    J Interferon Res; 1988 Dec; 8(6):727-33. PubMed ID: 3230331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype.
    Krasagakis K; Garbe C; Krüger S; Orfanos CE
    J Invest Dermatol; 1991 Aug; 97(2):364-72. PubMed ID: 1712824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic effect of human recombinant interferon-alpha 2a in combination with interferon-gamma and the induction of interferon-alpha 2a receptor by interferon-gamma.
    Ishii Y; Tsukagoshi S
    J Pharmacobiodyn; 1989 May; 12(5):299-304. PubMed ID: 2530332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation.
    Kumar R; Atlas I
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6599-603. PubMed ID: 1631162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antitumor effects of human natural and recombinant interferons (alpha and beta) on human cancer cell lines.
    Motoo Y; Hill NO; Osther K
    Jpn J Exp Med; 1986 Feb; 56(1):13-8. PubMed ID: 3014184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early modifications of nucleic acid metabolism and nuclear lipid biosynthesis associated with antiproliferative activity of interferon-alpha on Daudi lymphoma cells.
    Miscia S; Cataldi A; Grimley PM
    Exp Cell Res; 1990 Apr; 187(2):197-202. PubMed ID: 2318263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific binding of interferon-gamma and -alpha 2a to tumor cells and their antitumor activities.
    Ishii Y; Tsukagoshi S
    J Pharmacobiodyn; 1988 Jul; 11(7):465-71. PubMed ID: 3141606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effect of interferons on human prostate carcinoma cell lines.
    Sica G; Fabbroni L; Castagnetta L; Cacciatore M; Pavone-Macaluso M
    Urol Res; 1989; 17(2):111-5. PubMed ID: 2734978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective decrease in Leu8-negative T cell subpopulations following treatment with recombinant interferon-alpha 2a (rIFN-alpha 2a).
    Martínez-Maza O; Figlin RA; Giorgi JV; Fahey JL
    Cell Immunol; 1988 Nov; 117(1):89-98. PubMed ID: 2902935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta.
    Sperber SJ; Hayden FG
    J Interferon Res; 1989 Jun; 9(3):285-93. PubMed ID: 2545792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A membrane protein from IFN-beta-treated Daudi cells causes a cessation in cell growth.
    Hillman MC; Knight E; Blomstrom DC
    Biochem Biophys Res Commun; 1987 Oct; 148(1):140-7. PubMed ID: 3675571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.
    Darnowski JW; Davol PA; Goulette FA
    Biochem Pharmacol; 1997 Feb; 53(4):571-80. PubMed ID: 9105409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antiproliferative effects of glucocorticoids and interferon-alpha on some lymphoid cell lines.
    Elliott KR; Princler GL; Urba WJ; Faltynek CR
    J Cell Physiol; 1988 Jan; 134(1):85-92. PubMed ID: 3335582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced and down-regulated proteins in the human cultured hairy cell leukemia line JOK-1 and the Burkitt's lymphoma cell line Daudi during incubation with interferon-alpha: a kinetic study.
    Madsen PS; Nielsen B; Jensen AW; Justesen J; Ellegaard J; Hokland P; Hokland M
    J Interferon Res; 1992 Oct; 12(5):345-53. PubMed ID: 1431314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual modulation of phosphorylation of a 60 kDa nuclear protein in interferon-alpha treated Daudi cells.
    Kumar R
    Biochem Biophys Res Commun; 1995 Mar; 208(2):819-24. PubMed ID: 7535054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha.
    Flowers CC; Flowers SP; Nabel GJ
    Mol Med; 1998 Jun; 4(6):402-12. PubMed ID: 10780883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
    Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
    J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.